Sarcoidosis as a diagnostic challenge – a case report

Authors

DOI:

https://doi.org/10.14739/2310-1210.2025.2.314735

Keywords:

sarcoidosis, atypical presentations, diagnosis, differential diagnosis, biomarkers

Abstract

Sarcoidosis is considered a disease of unknown etiology which usually affects several organs and systems of the body and is manifested by the development of non-caseous granulomas. It is predominantly a multisystemic granulomatous disease that most often affects the respiratory and lymphatic systems, but varies clinically from patient to patient, making it difficult to diagnose correctly. The diagnosis is based on clinical and radiological data, the results of the sarcoidosis biomarker examinations, confirmed by the histological picture of non-caseous epithelioid cell granulomas. The use of modern instrumental methods of examination such as magnetic resonance imaging, high-resolution computed tomography, 18F-fluorodeoxyglucose-positron emission tomography has significantly improved the diagnosis of sarcoidosis.

Aim. The purpose of this paper is to present a clinical case of pulmonary sarcoidosis with atypical initial origin needed for additional differentiation and specific confirmation of the diagnosis.

Materials and methods. Diagnostic and differential diagnostic procedures were provided for a 24-year-old patient at the Therapeutic Department of the Regional Hospital of War Veterans (Chernivtsi, Ukraine). Complete examination included general clinical, laboratory and instrumental testing. Results of the clinical data were analyzed in dynamics, clinical diagnosis was confirmed by specific biomarkers, imagine tests and transbronchial lung biopsy with histology.

Results. The authors have presented the case of the 24-year-old man with atypical sarcoidosis associated with vertebrogenic thoraco-lumbalgia and persistent severe pain syndrome. He was admitted due to fever, increased temperature up to 37.2–37.4 °C, headache, muscular thoracic spine pain, unexplained general intoxication. He had a history of nephrectomy and mine-explosive injury. His specific objective findings were negative, but some nonspecific inflammatory biomarkers were imbalanced. Respiratory and inflammatory manifestations worsened in several days after admission that led to further diagnostic search and raised suspicion of sarcoidosis. Given the nonspecific clinical presentation and laboratory findings, the diagnosis needed a confirmation by chest computed tomography, sarcoidosis biomarkers and transbronchial lung biopsy with histology.

Conclusions. Thus, this case illustrates that even classic pulmonary sarcoidosis may started atypically, and diagnostic procedure requires extensive differentiation and specific confirmation by using modern diagnostic tools.

Author Biographies

V. O. Shuper, Bukovinian State Medical University, Chernivtsi

MD, PhD, Associate Professor of the Department of Internal Medicine, Clinical Pharmacology and Occupational Diseases

S. V. Trefanenko, Bukovinian State Medical University, Chernivtsi

MD, PhD, Associate Professor of the Department of Internal Medicine, Clinical Pharmacology and Occupational Diseases

S. V. Shuper, Yuriy Fedkovych Chernivtsi National University

MD, PhD, Associate Professor of the Department of Physical Rehabilitation, Ergotherapy and Pre-medical care

D. A. Trefanenko, Chernivtsi City Children’s Clinical Hospital

Physician of the Highest Category, Department of Surgery

References

Li CW, Tao RJ, Zou DF, Li MH, Xu X, Cao WJ. Pulmonary sarcoidosis with and without extrapulmonary involvement: a cross-sectional and observational study in China. BMJ Open. 2018;8(2):e018865. doi: https://doi.org/10.1136/bmjopen-2017-018865

Jain R, Yadav D, Puranik N, Guleria R, Jin JO. Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments. J Clin Med. 2020;9(4):1081. doi: https://doi.org/10.3390/jcm9041081

Arkema EV, Cozier YC. Epidemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic Dis. 2018;9(11):227-40. doi: https://doi.org/10.1177/2040622318790197

Ungprasert P, Carmona EM, Utz JP, Ryu JH, Crowson CS, Matteson EL. Epidemiology of Sarcoidosis 1946-2013: A Population-Based Study. Mayo Clin Proc. 2016;91(2):183-8. doi: https://doi.org/10.1016/j.mayocp.2015.10.024

Patterson KC, Chen ES. The pathogenesis of pulmonary sarcoidosis and implications for treatment. Chest. 2018;153(6):1432-42. doi: https://doi.org/10.1016/j.chest.2017.11.030

Carmi O, Berla M, Edelstein E, Levy Y. Coexisting Systemic Sclerosis-Polymyositis and Sarcoidosis: Case Report and Review of the Literature. J Clin Rheumatol. 2018;24(4):238-40. doi: https://doi.org/10.1097/RHU.0000000000000699

Kraaijvanger R, Janssen Bonás M, Vorselaars AD, Veltkamp M. Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects. Front Immunol. 2020;11:1443. doi: https://doi.org/10.3389/fimmu.2020.01443

Ozawa Y, Yamamoto H, Yasuo M, Komatsu M, Ushiki A, Hamano H, et al. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis. Nagoya J Med Sci. 2020;82(1):101-11. doi: https://doi.org/10.18999/nagjms.82.1.101

Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):736-55. doi: https://doi.org/10.1164/ajrccm.160.2.ats4-99

Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, et al. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(8):e26-e51. doi: https://doi.org/10.1164/rccm.202002-0251ST

Mirsaeidi M, Omar HR, Ebrahimi G, Campos M. The Association between ESR and CRP and Systemic Hypertension in Sarcoidosis. Int J Hypertens. 2016;2016:2402515. doi: https://doi.org/10.1155/2016/2402515

Schupp JC, Freitag-Wolf S, Bargagli E, Mihailović-Vučinić V, Rottoli P, et al. Phenotypes of organ involvement in sarcoidosis. Eur. Respir. J. 2018;51:1700991. doi: https://doi.org/10.1183/13993003.00991-2017

Della Zoppa M, Bertuccio FR, Campo I, Tousa F, Crescenzi M, Lettieri S, et al. Phenotypes and Serum Biomarkers in Sarcoidosis. Diagnostics (Basel). 2024;14(7):709. doi: https://doi.org/10.3390/diagnostics14070709

Dik WA, Heron M. Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases. Neth J Med. 2020;78(5):220-31.

Miyata J, Ogawa T, Tagami Y, Sato T, Nagayama M, Hirano T, et al. Serum soluble interleukin-2 receptor level is a predictive marker for EBUS-TBNA-based diagnosis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(1):8-16. doi: https://doi.org/10.36141/svdld.v37i1.8313

Downloads

Additional Files

Published

2025-04-29

How to Cite

1.
Shuper VO, Trefanenko SV, Shuper SV, Trefanenko DA. Sarcoidosis as a diagnostic challenge – a case report. Zaporozhye Medical Journal [Internet]. 2025Apr.29 [cited 2025May2];27(2):180-4. Available from: https://zmj.zsmu.edu.ua/article/view/314735